A Measurement Science Framework to Optimize CDS for Opioid Use Disorder Treatment in the ED.

IF 2.2 2区 医学 Q4 MEDICAL INFORMATICS
Applied Clinical Informatics Pub Date : 2025-08-01 Epub Date: 2025-08-20 DOI:10.1055/a-2595-0317
Mark S Iscoe, Carolina Diniz Hooper, Deborah R Levy, John Lutz, Hyung Paek, Christian Rose, Thomas Kannampallil, Daniella Meeker, James D Dziura, Edward R Melnick
{"title":"A Measurement Science Framework to Optimize CDS for Opioid Use Disorder Treatment in the ED.","authors":"Mark S Iscoe, Carolina Diniz Hooper, Deborah R Levy, John Lutz, Hyung Paek, Christian Rose, Thomas Kannampallil, Daniella Meeker, James D Dziura, Edward R Melnick","doi":"10.1055/a-2595-0317","DOIUrl":null,"url":null,"abstract":"<p><p>In the emergency department-initiated buprenorphine for opioid use disorder (EMBED) trial, a clinical decision support (CDS) tool had no effect on rates of buprenorphine initiation in emergency department (ED) patients with opioid use disorder. The Agency for Healthcare Research and Quality (AHRQ) recently released a CDS Performance Measure Inventory to guide data-driven CDS development and evaluation. Through partner co-design, we tailored AHRQ inventory measures to evaluate EMBED CDS performance and drive improvements.Relevant AHRQ inventory measures were selected and adapted using a partner co-design approach grounded in consensus methodology, with three iterative, multidisciplinary partner working group sessions involving stakeholders from various roles and institutions; meetings were followed by postmeeting surveys. The co-design process was divided into conceptualization, specification, and evaluation phases building on the Centers for Medicare and Medicaid Services' measure life cycle framework. Final measures were evaluated in three EDs in a single health system from January 1, 2023, to December 31, 2024.The partner working group included 25 members. During conceptualization, 13 initial candidate metrics were narrowed to 6 priority categories. These were further specified and validated as the following measures, presented with preliminary values based on the use of the current (i.e., preoptimization) EMBED CDS: eligible encounters with CDS engagement, 5.0% (95% confidence interval: 4.3-5.8%); teamwork on ED initiation of buprenorphine, 39.9% (32.5-47.3%); proportion of eligible users who used EMBED, 58.3% (50.9-65.8%); time spent on EMBED, 29.0 seconds (20.4-37.7 seconds); proportion of buprenorphine orders placed through EMBED, 6.5% (3.4-9.6%); and task completion, 13.8% (8.9-18.7%) for buprenorphine order/prescription.A measurement science framework informed by partner co-design was a feasible approach to develop measures to guide CDS improvement. Subsequent research could adapt this approach to evaluate other CDS applications.</p>","PeriodicalId":48956,"journal":{"name":"Applied Clinical Informatics","volume":" ","pages":"1067-1076"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12431813/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Clinical Informatics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2595-0317","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

In the emergency department-initiated buprenorphine for opioid use disorder (EMBED) trial, a clinical decision support (CDS) tool had no effect on rates of buprenorphine initiation in emergency department (ED) patients with opioid use disorder. The Agency for Healthcare Research and Quality (AHRQ) recently released a CDS Performance Measure Inventory to guide data-driven CDS development and evaluation. Through partner co-design, we tailored AHRQ inventory measures to evaluate EMBED CDS performance and drive improvements.Relevant AHRQ inventory measures were selected and adapted using a partner co-design approach grounded in consensus methodology, with three iterative, multidisciplinary partner working group sessions involving stakeholders from various roles and institutions; meetings were followed by postmeeting surveys. The co-design process was divided into conceptualization, specification, and evaluation phases building on the Centers for Medicare and Medicaid Services' measure life cycle framework. Final measures were evaluated in three EDs in a single health system from January 1, 2023, to December 31, 2024.The partner working group included 25 members. During conceptualization, 13 initial candidate metrics were narrowed to 6 priority categories. These were further specified and validated as the following measures, presented with preliminary values based on the use of the current (i.e., preoptimization) EMBED CDS: eligible encounters with CDS engagement, 5.0% (95% confidence interval: 4.3-5.8%); teamwork on ED initiation of buprenorphine, 39.9% (32.5-47.3%); proportion of eligible users who used EMBED, 58.3% (50.9-65.8%); time spent on EMBED, 29.0 seconds (20.4-37.7 seconds); proportion of buprenorphine orders placed through EMBED, 6.5% (3.4-9.6%); and task completion, 13.8% (8.9-18.7%) for buprenorphine order/prescription.A measurement science framework informed by partner co-design was a feasible approach to develop measures to guide CDS improvement. Subsequent research could adapt this approach to evaluate other CDS applications.

Abstract Image

Abstract Image

特刊上的CDS失败:测量科学框架,以优化CDS阿片类药物使用障碍治疗在ED。
目的:在急诊科发起的丁丙诺啡治疗阿片类药物使用障碍(EMBED)试验中,临床决策支持(CDS)工具对急诊科(ED)阿片类药物使用障碍患者丁丙诺啡启动率没有影响。医疗保健研究和质量机构(AHRQ)最近发布了一份CDS绩效衡量清单,以指导数据驱动的CDS开发和评估。通过合作伙伴共同设计,我们定制了AHRQ库存措施,以评估EMBED CDS的性能并推动改进。方法:选择相关的AHRQ清单措施,并采用基于共识方法的合作伙伴共同设计方法进行调整,其中包括三次迭代的多学科合作伙伴工作组会议,涉及来自不同角色和机构的利益相关者;会议之后进行会后调查。在医疗保险和医疗补助服务中心的测量生命周期框架的基础上,共同设计过程分为概念化、规范和评估阶段。在2023年1月1日至2024年12月31日期间,对同一卫生系统的3个急诊科进行最终措施评估。结果:合作伙伴工作组成员25人。在概念化过程中,13个初始候选指标被缩小到6个优先类别。这些被进一步指定并验证为以下措施,根据当前(即预优化)嵌入式CDS的使用给出初步值:合格的CDS接触,5.0% (95% CI: 4.3-5.8%);丁丙诺啡启动ED的团队合作占39.9% (32.5% ~ 47.3%);符合条件的用户使用EMBED的比例为58.3% (50.9% ~ 65.8%);嵌入时间29.0秒(20.4-37.7秒);通过嵌入式订购丁丙诺啡的比例为6.5% (3.4% ~ 9.6%);丁丙诺啡订单/处方完成率为13.8%(8.9% ~ 18.7%)。结论:合作伙伴共同设计的测量科学框架是制定指导CDS改进措施的可行方法。后续研究可以采用这种方法来评估其他CDS应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Applied Clinical Informatics
Applied Clinical Informatics MEDICAL INFORMATICS-
CiteScore
4.60
自引率
24.10%
发文量
132
期刊介绍: ACI is the third Schattauer journal dealing with biomedical and health informatics. It perfectly complements our other journals Öffnet internen Link im aktuellen FensterMethods of Information in Medicine and the Öffnet internen Link im aktuellen FensterYearbook of Medical Informatics. The Yearbook of Medical Informatics being the “Milestone” or state-of-the-art journal and Methods of Information in Medicine being the “Science and Research” journal of IMIA, ACI intends to be the “Practical” journal of IMIA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信